Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Avaliação multicêntrica de recuperação aprimorada após o protocolo de cirurgia na cirurgia de escoliose idiopática do adolescente (EMRACSIA)

23 de setembro de 2026 atualizado por: Hospices Civils de Lyon

Adolescent idiopathic scoliosis is a deformation of the spine affecting 2 to 4% of under 18 years old population. This can have severe physical or psychological impact during adulthood. The deformation causes mechanical constraints resulting in early osteoarthritis, which results in adulthood disability.

There is also an impact on the respiratory function in most severe cases of idiopathic scoliosis. Adolescents affected by a scoliosis with an angle of 40° of more undergo a surgery called posterior fusion during adolescence to limit these impacts.

In France, more than 1000 adolescent patients undergo a surgery called posterior spinal fusion for their severe scoliosis.

This aims to straighten the spine by bone grafting all the vertebras included in the scoliosis. Two metal rods are implanted to favour osteosynthesis of the straight spine.

This intervention suffer of a bad image and worries the patients and their parents, as it needs metal implants near the spinal cord.

The worry comes from the most severe complication that may happen exceptionally following this surgery, which is a definitive paraplegia. The scar is quite large and the surgery reduces the mobility of a part of the spine. The intervention produces a quite large haemorrhage, which leads to a diminution in haemoglobin level, resulting in a fatigue during the following weeks.

On the following days, the patient will need a specific protocol of pain management including morphine-based and anti-inflammatory drugs.

This intervention will often require a 5 to 7 days hospitalization with a 1 to 2 month convalescence period at home or in rehabilitation centre.

This intervention is performed on adolescent patients without comorbidities. Moreover, the surgical approach is not profound passing between the para-vertebral muscles with no close large blood vessels or major organs. The pain is caused by correction tensions and the access to the vertebras during the surgery.

Surgical techniques have considerably evolved allowing shorter interventions and to reduce the loss of blood.

The association between morphine-based treatments and grade I analgesics enables an effective pain management.

This intervention appears to perfectly suit to an enhanced recovery after surgery procedure (ERAS).

ERAS is a set of procedure meant to enhance its tolerance and to reduce its morbidity and the hospitalization duration after surgery and the recovery duration.

ERAS is well developed in adult patients undergoing surgery, it is also well described in paediatric patient especially on adolescent scoliosis surgeries.

As the pain is well controlled during the hospitalization as well when the patient get back home, there are very few obstacles to an ERAS procedure in this indication for a patient without comorbidities.

Numerous articles report experiences of medical staff with ERAS protocols.

Generally, the set of measures includes:

  • Before surgery: Providing information and therapeutic patient education, iron supplementation, physiotherapy, skin disinfection, digestive preparation against constipation
  • During surgery: recuperations of blood cells to limit blood loss, use of modern tools to facilitate the positioning of pedicle screws, surgery performed by 2 surgeons
  • After surgery: Pain management until stopping of analgesics by patient and maintenance of a link between the patient at home and the hospital staff after end of hospitalization The articles published about ERAS reports a favourable experience of such protocols with an efficient pain management, reduced hospitalization durations without increasing morbidity or re-hospitalizations. However, no studies have studied and proved by a robust scientific method the benefits of ERAS in adolescent scoliosis.

No studies evaluate the patients' quality of life or follow the patient for more than 6 months after surgery (limiting the assessment of long term complications e.g. infectious complications).

The link between hospital staff and the patient after his return back home is not described as well.

This research project aims to confirm with a robust scientific approach that ERAS protocols in idiopathic scoliosis in adolescents allow to reduce the duration of hospitalization compared to standard of care procedures while improving quality of life after surgery.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Estimado)

316

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

      • Amiens, França, 80054
        • Recrutamento
        • CHU d'Amiens Site Sud
        • Contato:
        • Investigador principal:
          • Richard GOURON, MD
      • Besançon, França, 25000
        • Recrutamento
        • CHU de Besançon Hopital Jean Minjoz
        • Contato:
        • Investigador principal:
          • Jeremie NALLET, MD
      • Bron, França, 69677
        • Recrutamento
        • Pediatric orthopedic surgery unit Hôpital femme Mère Enfant (HFME)
        • Contato:
        • Investigador principal:
          • Vincent CUNIN, MD
      • La Tronche, França, 38700
        • Recrutamento
        • CHU de Grenoble Hôpital Couple Enfant
        • Contato:
        • Investigador principal:
          • Aurélien COURVOISIER, MD
      • Lyon, França, 69322
        • Recrutamento
        • Centre Medico-Chirurgical de Réadaptation des Massues Croix-Rouge
        • Investigador principal:
          • Kariman ABELIN-GENEVOIS, MD
        • Contato:
      • Marseille, França, 13005
        • Recrutamento
        • AP-HM Hôpital de la Timone
        • Contato:
        • Investigador principal:
          • Sebastien PESENTI, MD
      • Nice, França, 06200
        • Recrutamento
        • Fondation LENVAL
        • Contato:
        • Investigador principal:
          • Frederico SOLLA, MD
      • Saint-Priest-en-Jarez, França, 42270
        • Recrutamento
        • CHU de Saint-Etienne Hôpital Nord
        • Contato:
        • Investigador principal:
          • Elie HADDAD, MD
      • Toulouse, França, 31059
        • Recrutamento
        • CHU de Toulouse
        • Contato:
        • Investigador principal:
          • Tristan LANGLAIS, MD
      • Toulouse, França, 31100
        • Recrutamento
        • Clinique Médipôle Garonne
        • Contato:
        • Investigador principal:
          • Roxane COMPAGNON, MD
      • Trélazé, França, 49800
        • Recrutamento
        • Clinique St Leonard
        • Contato:
        • Investigador principal:
          • Audrey ANGELLIAUME, MD

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

11 anos a 17 anos (Filho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Adolescents between 11 and 17 years old
  • Adolescent idiopathic scoliosis diagnosis
  • Posterior vertebral fusion surgery indicated to treat the patient
  • Informed consent signed by both parents / legal guardians

Exclusion Criteria:

  • Comorbidities that might influence the duration of hospitalization (e.g. respiratory failure, diabetes…)
  • Previous spine surgery
  • Patient not benefiting from an health insurance plan
  • Pregnant, parturient or breastfeeding woman
  • Patient benefiting of psychiatric care
  • Patient subject to a legal protection measure (guardianship, curatorship)

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Experimental group : Improved Recovery After Surgery

Patients in this group will undergo vertebral posterior fusion surgery with the Enhanced recovery after surgery protocol.

This will include at least:

  • A one-day hospitalization to visit the surgical unit and to provide therapeutic education to patients and their parents.
  • A transition to morphine based treatments per os from intravenous morphine on the second day following surgery
  • Phone calls from a surgery unit nurse 2 times a day during 5 days
  • A teleconsultation with the surgeon between D3 and D5 following surgery Patients will also have a first consultation with the anesthesist and the surgeon then the surgery will be planned.

They will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

This will include at least:

  • A one-day hospitalization to visit the surgical unit and to provide therapeutic education to patients and their parents.
  • A transition to morphine based treatments per os from intravenous morphine on the second day following surgery
  • Phone calls from a surgery unit nurse 2 times a day during 5 days
  • A teleconsultation with the surgeon between D3 and D5 following surgery
Experimental: Control group

Patients in this group will undergo posterior vertebral fusion surgery without the set of procedures for ERAS.

They will have a first consultation with the anesthesist and the surgeon then the surgery will be planned. The discharge from hospital after surgery will not happen early and the standard of care procedures will be followed during and after surgery.

Patients will receive 2 phone calls at D1 and D5 after surgery. The patient will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

Patients in this group will undergo posterior vertebral fusion surgery without the set of procedures for ERAS.

They will have a first consultation with the anesthesist and the surgeon then the surgery will be planned. The discharge from hospital after surgery will not happen early and the standard of care procedures will be followed during and after surgery.

Patients will receive 2 phone calls at D1 and D5 after surgery. The patient will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Demonstrate that ERAS in adolescent idiopathic scoliosis compared to standard of care procedure
Prazo: At Month 3 (Collected on the day of discharge from surgery hospitalization)

Hospitalization duration measured in days

At Month 3 (Collected on the day of discharge from surgery hospitalization)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Improvement of quality of life at one day after return at home
Prazo: Day 1 (VT1) after discharge from surgery hospitalization

Quality of life questionnaires (PedsQL) at day 1 after return at home 4-point scale : 0 if it's never a problem

  1. if it's almost never a problem
  2. if it's sometimes a problem
  3. if it's often a problem
  4. if it's almost always a problem
Day 1 (VT1) after discharge from surgery hospitalization
Improvement of quality of life at 5 days, 45 days and 12 months after return at home
Prazo: Day 1 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization

Quality of life questionnaires (PedsQL) at day 5, day 45 and month 12 after return at home 4-point scale : 0 if it's never a problem

  1. if it's almost never a problem
  2. if it's sometimes a problem
  3. if it's often a problem
  4. if it's almost always a problem
Day 1 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization
Changing post-surgical pain during hospitalization
Prazo: Day 0 (V3), day 1 (VT1), day 5 (VT3); day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization]

Visual analog pain scale during surgery hospitalization 10-point scale: 0: no pain 10: uncontrollable pain

Day 0 (V3), day 1 (VT1), day 5 (VT3); day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization]
Changing post-surgical pain at day 1, day 5, day 45 and month 12 after return at home
Prazo: Day 1 (VT1), day 5 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization

Visual analog pain scale 10-point scale: 0: no pain 10: uncontrollable pain

Day 1 (VT1), day 5 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization
Changing post-surgical complications at day 45 and month 12
Prazo: Day 45 (V4) and month 12 (V5)

Complications after surgery at day 45 and month 12 10-point scale: 0: no pain 10: uncontrollable pain

Day 45 (V4) and month 12 (V5)
Changing the rate of re-hospitalization during the 12 months following surgery
Prazo: From day of surgery day 0 (V3) to month 12 (V5)

Re-hospitalization rate during the 12 monts following surgery

From day of surgery day 0 (V3) to month 12 (V5)
Describe the acceptability of the early discharge date from hospitalization in the two arms by patients and their parents
Prazo: Day of surgery day 0 (V3)

Percentage of parents refusal for early discharge date

Day of surgery day 0 (V3)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

21 de setembro de 2026

Conclusão Primária (Estimado)

21 de agosto de 2030

Conclusão do estudo (Estimado)

21 de agosto de 2030

Datas de inscrição no estudo

Enviado pela primeira vez

7 de março de 2025

Enviado pela primeira vez que atendeu aos critérios de CQ

26 de março de 2025

Primeira postagem (Real)

3 de abril de 2025

Atualizações de registro de estudo

Última Atualização Postada (Real)

24 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

23 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever